About cmpath-admin

This author has not yet filled in any details.
So far cmpath-admin has created 13 blog entries.

CM-Path posts a BMJ Opinion Blog

CM-Path members Professor Manuel Salto-Tellez (Workstream 1 Co-Lead) and Dr David Moore (Workstream 1 member) have published a blog in the BMJ. The blog can be accessed here. Pathology risks being left behind as conceptual and technological advances accelerate Back in 2007 a diagnostic biopsy from a patient with lung cancer would frequently yield a [...]

By | January 2nd, 2018|Whats new|0 Comments

Training evolution in Pathology needed to deliver precision medicine in new genomics era

Training evolution in Pathology needed to deliver precision medicine in new genomics era The future delivery of precision medicine is at risk unless pathology training programmes evolve to embrace genomics, warn UK researchers, today (Wednesday). In two papers published in the British Journal of Cancer and the Journal of Clinical Pathology, the National Cancer Research [...]

By | November 8th, 2017|Whats new|0 Comments

CM-Path October 2017 Update

» Download the CM-Path October 2017 update here

By | October 11th, 2017|Whats new|0 Comments

How has Genomics Impacted Academic and Diagnostic Pathology?

On July 21st 2017, Workstream 1 of CM-Path organised a workshop to discuss the impact of genomics in academic and diagnostic pathology. Key stakeholders from across the UK convened at the Medical Research Council to discuss the need for a change in the postgraduate pathology training programme to move towards a true morpho-molecular discipline. Throughout [...]

By | July 22nd, 2017|Whats new|0 Comments

CM-Path Hosts Genomic Education Day with Health Education England LaSE School of Pathology

On July 20th 2017, Dr Richard Haspel from the Beth Israel Deaconess Medical Center, United States, delivered the Training Residents in Pathology (TRIG) workshop for over 80 pathology trainees in the UK. The day was organised by Workstream 1 of CM-Path and Heath Education England London and South East School of Pathology, with special thanks [...]

By | July 21st, 2017|Whats new|0 Comments

CM-Path Trainees Present Survey Data at PathSoc Belfast 2017

CM-Path Trainee Histopathologists Dr Scarlet Brockmoeller and Dr Caroline Young (both of University of Leeds) delivered a plenary presentation at PathSoc Belfast 2017. They presented findings from a comprehensive survey distributed to UK-based consultant pathologists that captured information regarding attitudes towards academia and molecular pathology. Detailed findings are now being prepared for submission of a [...]

By | June 21st, 2017|Whats new|0 Comments

Dr Clare Verrill is Appointed as CM-Path Workstream 4 Lead

Dr Clare Verill has been appointed as CM-Path Workstream 4 Lead. Clare is a urological pathology consultant, having achieved her CCT in 2008.  She works for Oxford University as Senior Lecturer in Pathology, but spends approximately 50% of her time working for the NHS. Her primary interests are testis and prostate and she is [...]

By | June 6th, 2017|Whats new|0 Comments

CM-Path Hosts Workshop “Current and Future Challenges for Innovative Biomarker Development”

The CM-Path workshop ‘Current and Future Challenges for Innovative Biomarker Development’ was organised by Dr Maggie Cheang and held on 12 April at the Royal Society of Medicine. The day brought together a number of medical specialities including pathologists, oncologists, statisticians, translational scientists and others. Consumer representatives were also in attendance on the day challenging [...]

By | May 15th, 2017|Whats new|0 Comments

CM-Path Consumer Spends a Day in the Glasgow Diagnostic Pathology Lab

CM-Path members Dr Jane Hair (Discovery Workstream), Dr Hayley Morris (Skills and Capacity Workstream Trainee), Dr Tomoko Iwata (Skills and Capacity Workstream) and Dr Karin Oien (CM-Path Chairperson) hosted Tom Haswell, CM-Path consumer, on the 30th March 2017. Tom learnt about the importance of pathology in a cancer patients diagnosis and journey, he says: I [...]

By | April 3rd, 2017|Whats new|0 Comments

CM-Path Recognises the Need for Quality Assurance in Clinical Trials

Dr Clare Verrill organised a meeting on the 21st March 2017 attended by CM-Path members, as well as representatives from the MHRA, Genomics England, industry, clinical trial units, Cancer Research UK and the Experimental Cancer Medicine Centres. Following on from several teleconferences, the day aimed to identify best practice guidance for quality assurance in clinical [...]

By | March 21st, 2017|Whats new|0 Comments